A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy. . . . → Read More: Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
|
|||||
       |
 Comments are closed  Finance, Joint ventures/collaborations  biomedical, biotechnology, chemistry, clinical trials, DoD, entrepreneurs, grant, life sciences, pharmaceuticals, physical sciences, preclinical, psychiatric, university 
A genomics company is providing precision medicine analytics from its databases with generative A.I. based on large language models from Amazon Web Services. . . . → Read More: Genomics Company, Amazon Partner on Generative A.I. One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, computer science, engineering, entrepreneurs, genomics, life sciences, mathematics, medical device, physical sciences, software 
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances. . . . → Read More: Biosensor Developed to Detect Explosives, Land Mines Comments are closed Joint ventures/collaborations, New products biotechnology, chemistry, engineering, entrepreneurs, genomics, Israel, life sciences, mathematics, physical sciences, university 
The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat. . . . → Read More: Infographic – Q2 Tech Merger Values Up, Deals Down Comments are closed Finance biotechnology, engineering, equity, investment, mathematics, merger, robotics, software, statistics 
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases. . . . → Read More: University Start-Up Developing Inhaled Gene Therapies 
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds. . . . → Read More: Autoimmune Neuro Disease Start-Up Raises $58M One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, FDA, investment, life sciences, pharmaceuticals, preclinical, psychiatric, venture capital 
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies. . . . → Read More: Neurons from Stem Cells Produced for Overdose Therapy Tests Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, engineering, health care, life sciences, medical device, physical sciences, preclinical, stem cells, university 
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company 
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections. . . . → Read More: Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria Comments are closed New products biomedical, biotechnology, clinical trials, health care, life sciences, pharmaceuticals, U.K., university 
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders. . . . → Read More: Trial Begins for Multi-Neurological Disease Therapy Comments are closed New products biomedical, biotechnology, chemistry, clinical trials, life sciences, pharmaceuticals, physical sciences, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts